Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B

P. Marcellin; S. H. Ahn; W.-L. Chuang; A. J. Hui; F. Tabak; R. Mehta; J. Petersen; C.-M. Lee; X. Ma; F. A. Caruntu; W. Y. Tak; M. Elkhashab; L. Lin; G. Wu; E. B Martins; P. Charuworn; L. J. Yee; S. G. Lim; G. R. Foster; S. Fung; L. Morano; D. Samuel; K. Agarwal; R. Idilman; S. I. Strasser; M. Buti; G. B. Gaeta; G. Papatheodoridis; R. Flisiak; H. L. Y. Chan

doi:10.1111/apt.13779

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.13779 ◽

2016 ◽

Vol 44 (9) ◽

pp. 957-966 ◽

Cited By ~ 22

Author(s):

P. Marcellin ◽

S. H. Ahn ◽

W.-L. Chuang ◽

A. J. Hui ◽

F. Tabak ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Predictors Of Response ◽

Peginterferon Alfa

Download Full-text

Compare with safety and efficacy of entecavir and adefovir dipivoxil combination therapy and tenofovir disoproxil fumarate monotherapy for chronic hepatitis B patient with adefovir-resistant

Mathematical Biosciences and Engineering ◽

10.3934/mbe.2020032 ◽

2020 ◽

Vol 17 (1) ◽

pp. 627-635

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Adefovir Dipivoxil ◽

Safety And Efficacy

Download Full-text

HBsAg Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2A in Chronic Hepatitis B: Long-Term Results of a Global Randomized Controlled Trial

Journal of Hepatology ◽

10.1016/s0168-8278(16)00924-7 ◽

2016 ◽

Vol 64 (2) ◽

pp. S524-S525

Author(s):

S.-H. Ahn ◽

P. Marcellin ◽

X. Ma ◽

F. Caruntu ◽

W.Y. Tak ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Controlled Trial ◽

Long Term Results ◽

Randomized Controlled ◽

Peginterferon Alfa

Download Full-text

Switching Tenofovir Disoproxil Fumarate (TDF) plus Entecavir Combination Therapy to TDF Monotherapy is Safe and Efficacious in Patients with Multiple Drug-resistant Chronic Hepatitis B: Randomized Trial

Journal of Hepatology ◽

10.1016/s0168-8278(16)01120-x ◽

2016 ◽

Vol 64 (2) ◽

pp. S606 ◽

Cited By ~ 1

Author(s):

Y.-S. Lim ◽

B.C. Yoo ◽

K.S. Byun ◽

S.Y. Kwon ◽

Y.J. Kim ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Randomized Trial ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Multiple Drug ◽

Drug Resistant ◽

Multiple Drug Resistant

Download Full-text

Switching to Tenofovir Disoproxil Fumarate and Lamivudine Combination Therapy in Patients With Chronic Hepatitis B and Poor Response to Adefovir and Lamivudine Combination Therapy

The American Journal of Gastroenterology ◽

10.14309/00000434-201510001-02112 ◽

2015 ◽

Vol 110 ◽

pp. S883-S884

Author(s):

Eiji Mita ◽

Hisashi Ishida ◽

Yasuharu Imai ◽

Michio Kato ◽

Hajime Ohta ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Poor Response

Download Full-text

Quantitative Analysis of Hepatic CCCDNA during Combination Therapy of Peginterferon ALFA 2B Plus Adefovir Dipivoxil in Patients with Chronic Hepatitis B: Interim Analysis of a single Center Pilot Study

Zeitschrift für Gastroenterologie ◽

10.1055/s-2004-831755 ◽

2004 ◽

Vol 42 (08) ◽

Author(s):

K Wursthorn ◽

P Buggisch ◽

F Metzler ◽

B Zöllner ◽

M Zankel ◽

...

Keyword(s):

Chronic Hepatitis ◽

Quantitative Analysis ◽

Pilot Study ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Interim Analysis ◽

Adefovir Dipivoxil ◽

Single Center ◽

Peginterferon Alfa

Download Full-text

O117 : Predictors of clinical response: Results from a large, randomized controlled study with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)

Journal of Hepatology ◽

10.1016/s0168-8278(15)30136-7 ◽

2015 ◽

Vol 62 ◽

pp. S251-S252 ◽

Cited By ~ 7

Author(s):

H.L. Chan ◽

S.H. Ahn ◽

W.L. Chuang ◽

A.J. Hui ◽

F. Tabak ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Clinical Response ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Randomized Controlled Study ◽

Controlled Study ◽

Randomized Controlled ◽

Peginterferon Alfa

Download Full-text

A case of chronic hepatitis B which achieved hepatitis B surface antigen seroclearance during combination therapy with peginterferon alfa-2b and entecavir

Kanzo ◽

10.2957/kanzo.53.42 ◽

2012 ◽

Vol 53 (1) ◽

pp. 42-47

Author(s):

Tadashi Inuzuka ◽

Yukio Osaki ◽

Fumihiro Matsuda ◽

Azusa Sakamoto ◽

Keiichi Hatamaru ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Surface Antigen ◽

Hepatitis B Surface Antigen ◽

Peginterferon Alfa

Download Full-text

O113 COMBINATION THERAPY WITH PEGINTERFERON ALFA-2a AND A NUCLEOS(T)IDE ANALOGUE FOR HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: RESULTS OF A LARGE, RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(14)60115-x ◽

2014 ◽

Vol 60 (1) ◽

pp. S47 ◽

Cited By ~ 9

Author(s):

W.-W. Su ◽

C.-W. Hsu ◽

C.-M. Lee ◽

C.-Y. Peng ◽

W.-L. Chuang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Positive Chronic Hepatitis ◽

Peginterferon Alfa

Download Full-text

Efficacy of tenofovir disoproxil fumarate switch therapy in chronic hepatitis B patients with suboptimal response to adefovir‑based combination therapy

Experimental and Therapeutic Medicine ◽

10.3892/etm.2018.7081 ◽

2018 ◽

Author(s):

Xiangyong Li ◽

Jie Luo ◽

Changhao Zhu ◽

Yuankai Wu ◽

Zhanyi Li ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Switch Therapy

Download Full-text

Durability of HBEAG seroconversion in chronic hepatitis B patients after lamivudine A-interferon or lamivudine A-interferon combination therapy

Journal of Hepatology ◽

10.1016/s0168-8278(01)80565-1 ◽

2001 ◽

Vol 34 (0) ◽

pp. 155 ◽

Cited By ~ 1

Author(s):

A Van Nunen

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Hbeag Seroconversion

Download Full-text